Neuropsychopharmacology
Publisher: Elsevier · ISSN 0893-133X · 61 articles
- Functional genomic profiling of schizophrenia-associated genes reveals key microglial regulators
- Sensorimotor circuit connectivity as a candidate biomarker for responsiveness to sertraline in obsessive–compulsive disorder
- Cannabidiol corrects sleep deficits and reduces spontaneous seizures in Angelman syndrome model mice
- IN MEMORIUM - Roger E. Meyer, MD
- Effects of NMDA receptor antagonists on working memory and gamma oscillations, and the mediating role of the GluN2D subunit
- Older and wiser? The neural correlates of worry induction and reappraisal in older adults
- Epigenetic manipulation of anterior insular cortex alters neural signals and cognitive control
- Carvone derived cannabidiol enantiomers as novel anticonvulsants
- Medial nucleus accumbens dopamine receptors modulate motivation for wheel running in male mice
- A Drd1-cre mouse line with nucleus accumbens gene dysregulation exhibits blunted fentanyl seeking
- Cocaine self-administration in adult female and male rhesus monkeys: longitudinal comparison with adolescent behavior and role of early life stress
- Ro 64-6198, a selective NOP receptor agonist attenuates social impairments associated with NTG-induced migraine pain
- Clozapine induces perineuronal net remodeling in a developmental mouse model exhibiting schizophrenia-relevant phenotypes
- Disentangling the effects of corticotrophin releasing factor and GABA release from the bed nucleus of the stria terminalis on ethanol self-administration in mice
- Targeting GPR3 as a novel approach for nicotine cessation therapeutic development
- Concerted elevations of cortical and striatal glutamate and GABA in antipsychotic-free individuals at clinical high-risk for psychosis
- Optimizing social media initiatives to promote Neuropsychopharmacology (NPP) publications
- A highly D3R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D3R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder
- TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT1A receptor agonist SEP-363856
- The BNST balances alcohol’s aversive and rewarding properties
- Heightened fear in the absence of the kainate receptor auxiliary subunit NETO2: implications for PTSD
- Ethanol-induced conditioned place preference and aversion differentially alter plasticity in the bed nucleus of stria terminalis
- Kainate receptor auxiliary subunit NETO2 is required for normal fear expression and extinction
- The cycling brain: menstrual cycle related fluctuations in hippocampal and fronto-striatal activation and connectivity during cognitive tasks
- Reduced nucleus accumbens enkephalins underlie vulnerability to social defeat stress
- Nucleus accumbens shell small conductance potassium channels underlie adolescent ethanol exposure-induced anxiety
- Inhibition of the rostromedial tegmental nucleus reverses alcohol withdrawal-induced anxiety-like behavior
- Profound alteration in reward processing due to a human polymorphism in CHRNA5: a role in alcohol dependence and feeding behavior
- Randomized, double-blind, placebo-controlled study of F17464, a preferential D3 antagonist, in the treatment of acute exacerbation of schizophrenia
- Neural and behavioral effects of oxytocin administration during theory of mind in schizophrenia and controls: a randomized control trial